In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
Read More
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. And there’s a North Carolina connection.
Read More
Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effectively, and allows for self-administration via an inhaler.
Read More
Omicron subvariants BA.4 and BA.5 appear to escape antibody responses among both people who had previous Covid-19 infection and those who have been fully vaccinated and boosted, according to new data from researchers at Beth Israel Deaconess Medical Center, of Harvard Medical School. However, Covid-19 vaccination is still expected to provide substantial protection.
Read More
“North Carolina has prioritized bringing all its assets together to manufacture products and create a workforce to develop those lifesaving products. We’ve needed them for COVID, and we’re going to need them for other things,” a White House official says. Here are the details.
Read More
The U.S. has ordered 20 million courses of Paxlovid from the drugmaker Pfizer, and the country risks running out this winter if the drug continues to be used widely. The White House has been pressing Congress for additional funds for months to support purchasing more Paxlovid and other treatments, as well as additional boosters.
Read More
The University of North Carolina at Chapel Hills is getting $65 million from the National Institutes of Health to prepare for the next pandemic. The money will be used to establish an Antiviral Drug Discovery Center.
Read More
A study published in The Lancet Digital Health led by UNC School of Medicine’s Emily R. Pfaff, PhD, shows how the National COVID Cohort Collaborative used XGBoost machine learning models to better define long COVID and identify potential long COVID patients with a high degree of accuracy. Here are the details.
Read More
So, now that I’m recovered, we’re done here, right? Ha! COVID is a reminder that all our misadventures – in love, business, medicine – are but prelude to more misadventures. COVID came out of the blue, and there’s still lots of blue out there. Let me share my latest experience …
Read More
